Skip to main content

US ClosedU.S. Closed

EVMN: Evommune, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions.

52W Range

12thpctl

Volume

0.53×avg

Market Cap

480.14MUSD

P/E Ratio

-4.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Evommune, Inc.

EVMNNew York Stock Exchange·USD·Closed

Evommune, Inc.

EVMNNew York Stock Exchange·USD·Closed

$13.23

−1.85%

$13.23

−$0.25 (1.85%)

52W Range

12thpctl

Volume

0.53×avg

Mkt Cap

480.14MUSD

P/E

-4.7TTM

Div Yield

–ann